For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Marathon Petroleum Corp. (MPC) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-08): Designation Watch · Gem Score +2 (−100…+100 Quality+Value blend) · Quality 13 · Value -6 · Sentiment 38 (timing only, not weighted) · Composite fair value $590.25 vs $382.99 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Marathon Petroleum Corp.
MPC NYSEMarathon Petroleum Corp. is an integrated downstream and midstream energy company headquartered in Findlay, Ohio. Marathon Petroleum Corp. operates a large refining network that processes crude oil into transportation fuels and other petroleum products, while also handling storage, transportation, and marketing activities that move those products through the supply chain. Its business includes branded retail and wholesale fuel distribution across the United States, as well as ownership interests in MPLX LP, which supports gathering, processing, fractionation, and logistics infrastructure for crude oil and light products. The company also participates in renewable diesel operations, adding another segment to its broader energy portfolio. Marathon Petroleum Corp. plays a central role in U.S. fuel supply and energy logistics through its refining, marketing, and midstream capabilities.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 13.22
Total Equity: $24.09B
Shares: 306,000,000
Total Debt: $32.88B
Cash: $3.67B
EBITDA: $11.54B
Total Debt: $32.88B
Cash: $3.67B
Revenue: $132.70B
Revenue: $132.70B
Revenue: $132.70B
Total Equity: $24.09B
Tax Rate: 16.2%
Equity: $24.09B
Total Debt: $32.88B
Cash: $3.67B
Current Liabilities: $19.68B
Long-Term Debt: $30.51B
Total Debt: $32.88B
Total Equity: $24.09B
Shares: 306,000,000
Shares: 306,000,000
CapEx: -$3.49B
Shares: 306,000,000
Stock Price: $383.00
Net Income: $4.05B
Industry Benchmarks
Income Statement (Annual)
Last updated: Sep 1, 2026 11:36pm (36d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $120.0B | $177.5B | $148.4B | $138.9B | $132.7B |
| Cost of Revenue | $110.0B | $151.7B | $128.6B | $126.2B | $119.4B |
| Gross Profit | $10.0B | $25.8B | $19.8B | $12.6B | $13.3B |
| Operating Expenses | $5.7B | $4.3B | $5.3B | $5.8B | $5.0B |
| Operating Income | $4.3B | $21.5B | $14.5B | $6.8B | $8.3B |
| Net Income | $9.7B | $14.5B | $9.7B | $3.4B | $4.0B |
| EBITDA | $7.7B | $24.7B | $17.8B | $10.1B | $11.5B |
| EPS | $34.68 | $51.69 | $34.47 | $10.11 | $13.24 |
| EPS (Diluted) | $34.46 | $51.29 | $34.30 | $10.08 | $13.22 |
Balance Sheet (Annual)
Last updated: Sep 1, 2026 11:30pm (36d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5.3B | $8.6B | $5.4B | $3.2B | $3.7B |
| Total Current Assets | $30.5B | $35.2B | $32.1B | $24.4B | $24.8B |
| Total Assets | $85.4B | $89.9B | $86.0B | $78.9B | $84.0B |
| Current Liabilities | $17.9B | $20.0B | $20.2B | $20.8B | $19.7B |
| Long-Term Debt | $25.0B | $25.6B | $25.3B | $24.4B | $30.5B |
| Total Liabilities | $51.8B | $54.8B | $54.6B | $54.4B | $59.9B |
| Total Equity | $33.6B | $35.1B | $31.4B | $24.5B | $24.1B |
| Retained Earnings | $12.9B | $26.1B | $34.6B | $36.8B | $39.8B |
Cash Flow (Annual)
Last updated: Sep 1, 2026 11:52pm (36d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $16.4B | $14.1B | $8.7B | $8.3B |
| Capital Expenditure | -$1.5B | -$2.4B | -$1.9B | -$2.5B | -$3.5B |
| Free Cash Flow | $2.9B | $13.9B | $12.2B | $6.1B | $4.8B |
| Acquisitions (net) | $0 | -$413.0M | -$246.0M | -$688.0M | -$3.3B |
| Net Debt Issued / (Repaid) | -$17.4B | -$2.3B | -$1.1B | -$2.0B | -$6.5B |
| Dividends Paid | -$1.5B | -$1.3B | -$1.3B | -$1.2B | -$1.1B |
| Stock Buybacks | -$4.7B | -$11.9B | -$11.6B | -$9.2B | -$3.5B |
| Net Change in Cash | — | — | — | — | — |
Growth Trends (YoY %)
Last updated: Sep 1, 2026 11:36pm (36d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +47.9% | -16.4% | -6.4% | -4.4% |
| Gross Profit Growth | +158.5% | -23.2% | -36.3% | +5.0% |
| Operating Income Growth | +399.3% | -32.4% | -53.2% | +22.0% |
| Net Income Growth | +49.1% | -33.3% | -64.4% | +17.5% |
| EBITDA Growth | +222.1% | -27.8% | -43.1% | +13.9% |
Dividend History (Last 20)
Last updated: Sep 1, 2026 11:30pm (36d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-19 | $1.00 | — | — | — |
| 2026-05-20 | $1.00 | — | — | — |
| 2026-02-18 | $1.00 | — | — | — |
| 2025-11-19 | $1.00 | — | — | — |
| 2025-08-20 | $0.91 | — | — | — |
| 2025-05-21 | $0.91 | — | — | — |
| 2025-02-19 | $0.91 | — | — | — |
| 2024-11-20 | $0.91 | — | — | — |
| 2024-08-21 | $0.83 | — | — | — |
| 2024-05-15 | $0.83 | — | — | — |
| 2024-02-20 | $0.83 | — | — | — |
| 2023-11-15 | $0.83 | — | — | — |
| 2023-08-15 | $0.75 | — | — | — |
| 2023-05-16 | $0.75 | — | — | — |
| 2023-02-15 | $0.75 | — | — | — |
| 2022-11-15 | $0.75 | — | — | — |
| 2022-08-16 | $0.58 | — | — | — |
| 2022-05-17 | $0.58 | — | — | — |
| 2022-02-15 | $0.58 | — | — | — |
| 2021-11-16 | $0.58 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-06 02:02A +1σ run of quarters pays +178%; a −1σ run costs 65%. Ratio 2.8:1 (μ 9.4%, σ 25.6% , 16 pairs).
Older method (repeat-worst-quarter): 51.6 : 1
| Case | Growth | Margin | Fair value | vs price ($382.99) |
|---|---|---|---|---|
| Bull — recovery | +28% | 17.3% | $2,343.54 | +512% |
| Base — stabilizes | +18% | 15.0% | $1,549.49 | +305% |
| Bear — keeps slipping | +9% | 12.8% | $987.97 | +158% |
| Stress — last quarter repeats | -2% | 6.1% | $344.97 | -10% |
| Upside — a +1σ run of quarters (v2) | +35% | 6.1% | $1,065.77 | +178% |
| Stress — a −1σ run of quarters (v2) | -16% | 3.8% | $135.73 | -65% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-02 00:01The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The Q2 2026 print is the elephant nobody's addressing cleanly: $51.99B revenue with $5.14B net income at 9.9% margin is not a mature-earner data point — it's a crack-spread spike or a one-time gain. Compare it to the trailing four quarters averaging ~$33B revenue at 2-4% margins, and the sequential jump from $34.2B to $52B in one quarter with net income going from $511M to $5.14B looks like either a windfall quarter (geopolitical crude dislocation, hurricane-driven product shortages) or a data artifact. Either way, annualizing this into any DCF is malpractice. If real and sustained, MPC prints ~$15-20B of NI at run-rate and $383 is absurdly cheap at ~5-7x. If it's a one-off and normalized earnings are the $3-4B range implied by the other seven quarters, then $383 on ~$4B NI is ~27x — expensive for a declining refiner. The synthesis verdict's $623 fair value depends entirely on which read you accept, and it doesn't defend the choice.
The synthesis model's +62.9% upside call is not credible without unpacking the Q2 anomaly. A $700 composite fair value on a refiner trading with -5.4% revenue CAGR and -35% earnings CAGR requires heroic terminal assumptions. The Market Forces model's "value trap" framing is more honest about the structural setup — refining is a sunset industry in slow motion, gasoline demand peaks are visible, and 2022's $14.5B NI was cyclical peak, not a baseline. But Market Forces also under-weights the capital return machine: MPC has aggressively bought back stock (share count down materially since 2021), and MPLX midstream provides ~$2B+ of steady distributions annually that anchor a floor. The Thesis Evaluation's -12 score captures the tension best — this is not a screaming short nor a screaming buy; it's a coin flip on mid-cycle margins with the market currently pricing the bearish tail.
A careful contrarian would argue two things. First, the debt load ($32.88B vs $24.09B equity, D/E 1.36) is dangerous in a genuine down-cycle — if crack spreads collapse in 2027-28, FCF of $4.77B could halve and dividend coverage tightens fast, especially with 28% payout already. Second, the insider activity is quietly bearish: seven transactions listed, zero opportunistic buys, multiple option-exercise-and-sell combinations. Not damning, but no insider is treating $383 as a bargain. The bull case that MPC compounds via buybacks only works if mid-cycle NI is $6-8B, not $3-4B; at $4B run-rate NI and current $107B market cap, you're paying 27x for a business with negative revenue CAGR. That's not undervalued — that's fairly valued to slightly rich given the terminal risk.
I dissent from the synthesis "undervalued +62.9%" verdict — the DCF is anchored to peak-cycle assumptions that the -35% earnings CAGR explicitly refutes. I lean toward Market Forces' framing but stop short of "value trap" because the Q2 2026 print, if real and repeatable, changes the math. The honest read is: fair value $350-420 depending on whether you weight normalized NI at $4B (bearish, ~$310) or $6B (bullish, ~$450). Current $383 is smack in the middle. The stock is a hold, not a buy — the +63% upside claim requires evidence that Q2 2026's 9.9% margin is a new floor, and one quarter is not evidence. I want to see Q3 2026 before committing capital either direction. If Q3 prints another >$4B NI quarter, re-rate to bullish; if it reverts to $1-1.5B, the terminal-decline bears are right and $383 becomes a short candidate near $320.
GPT Reading
The raw numbers do not support the idea that Marathon is obviously cheap at $383. This is a refiner whose annual earnings power has already rolled hard from the 2022–2023 windfall: net income fell from $14.5B in 2022 and $9.7B in 2023 to $3.45B in 2024 and $4.05B in 2025, while revenue slid from $177.5B to $132.7B over that span. On 2025 figures, the stock is being asked to trade at roughly 29x earnings, 12.1x EV/EBITDA, 4.9x book, and about 22.5x free cash flow using the $4.77B FCF number against a $107.6B equity value. Those are not distress or even normal cyclical-refiner multiples; they imply either a major rebound in normalized earnings or that a large portion of the value deserves utility-like treatment because the business mix is better than the headline “refiner” label suggests. The first half of 2026 shows why the market is willing to pay up: Q1 was weak at just $511M of net income on $34.2B of revenue, but Q2 snapped to $5.14B on $52.0B, a 9.9% net margin that looks much closer to a favorable refining environment. Even annualizing that quarter would be reckless, but it tells you the earnings floor from 2024–2025 was not the whole story either.
What stands out most is that the market cap is being supported by volatility, not by demonstrated stability. Quarterly net income has swung from a $74M loss in 2025 Q1 to $1.2B–$1.5B through much of 2025, then down to $511M in 2026 Q1, then up to $5.14B in 2026 Q2. That is exactly the kind of earnings stream that should get a discounted multiple unless the balance sheet and cash return policy are overwhelmingly strong. The balance sheet is fine, not fortress-like: $32.9B of debt against $3.7B of cash and $24.1B of equity leaves net debt heavy enough that I do not want to underwrite the stock on “asset value” alone, especially at 1.05x EV/revenue in a low-margin business. Returns are respectable — 16.8% ROE and 13.0% ROIC on the latest annual basis — but those metrics are being cited off a year when net margin was only 3.1%. If the business were really earning near-cycle trough profits, I’d expect cheaper valuation support than this. Instead, the stock appears priced for a pretty healthy mid-cycle margin regime to persist.
That is where I part ways with the more aggressive undervaluation models. A DCF that spits out $620–$700 fair value is almost certainly capitalizing a recovery too generously or assuming today’s earnings volatility smooths into durable high cash generation. The actual evidence is that free cash flow in 2025 was $4.77B after $3.49B of capex, solid but not spectacular versus a $107.6B market cap, and the business has posted negative revenue CAGR of 5.4% and earnings CAGR of negative 35.3% over the measured period. The recent Q2 surge matters, but the stock is already at a level where investors are paying for that rebound before seeing whether it repeats. In my read, this is not a classic “market prices in collapse” setup; it is a market paying a premium for optionality on crack spreads and for the possibility that the company’s asset quality can keep earnings above the ugly 2024–2025 run rate. That may work tactically, but it is not undervaluation in a fundamental sense.
The best argument against my view is straightforward: if you take the last four quarters shown — 2025 Q3 through 2026 Q2 — net income totals about $8.56B, which drops the effective trailing P/E closer to 12.5x rather than 29x. On that lens, the stock no longer looks expensive for a company that may be re-entering a stronger margin period, and Q2 2026’s $5.14B profit suggests the operating leverage is enormous when conditions improve. Annual operating cash flow of $8.25B and a 1.26 current ratio also indicate the company is not financially strained, while ROIC above 13% implies the assets still earn more than a commodity-multiple business might deserve. A smart bull would also say that focusing on 2025 annual FCF misses what happens when margins normalize higher: buybacks and dividends can quickly compress the share count and make today’s price look fine in hindsight. I weigh that evidence less heavily because one quarter of near-10% net margin in refining should not be treated as a new baseline, and because the valuation already embeds more faith in normalized recovery than bears seem to admit.
What would change my mind is evidence that the stronger 2026 quarter is not a spike. If the next two quarters can sustain revenue in at least the mid-$40B range and produce combined net income above roughly $5B without an obvious one-off, then the case for $8B–$10B annualized earnings power becomes much more credible and $383 would look fair to modestly cheap. I would also turn more constructive if annual free cash flow moves decisively above $8B while debt trends down from $32.9B, because then the current equity value would be supported by actual cash yield rather than cyclical hope. On the other hand, if earnings slip back toward the 2025 pattern of $1B-ish quarterly profitability, the stock is plainly too rich and should de-rate materially, likely into the low $300s or below.
Grok Reading
The raw numbers describe a classic refining cycle that has already rolled over from the 2022 peak, not a growth compounder. Annual revenue fell from $177.5B in 2022 to $132.7B in 2025; net income collapsed from $14.5B to $4.05B over the same span, a −35% earnings CAGR that matches the free-cash-flow drawdown (−38%). Operating margin compressed from the mid-teens to 6.3%, net margin to 3.1%. Balance-sheet leverage is real: $32.9B of debt against $24.1B of equity and only $3.7B of cash, producing a 1.36 debt-to-equity ratio that leaves limited room for error if crack spreads stay soft. On 2025 earnings the stock screens expensive at 29× trailing and 12.1× EV/EBITDA with a 4.9× price-to-book—multiples that historically appear only when the market is already pricing a mid-cycle rebound or when share count has been aggressively retired. The single data point that breaks the clean “terminal decline” story is the June 2026 quarter: $52.0B revenue and $5.14B of net income at a 9.9% margin, more profit in thirteen weeks than the entire prior year. That print, plus the still-positive $4.8B of annual free cash flow and a sub-30% payout ratio, is why the equity sits near cycle highs rather than trading like a melting ice cube. Insiders, however, have been net sellers around the $380 area, which is consistent with a stock that has already discounted a lot of good news.
The valuation synthesis that spits out $624–$702 is the main object I refuse to accept at face value. It embeds mid-cycle margins and terminal growth that the multi-year revenue and FCF CAGRs simply do not support; treating 2022–2023 as a base rather than a once-in-a-decade crack-spread windfall is the error. At the same time the “value-trap / structural sunset” camp overstates the immediacy of EV-driven demand destruction: gasoline demand has not collapsed, refining capacity remains tight on the Gulf Coast, and the MPLX midstream drop-down still converts into durable cash that funds buybacks. The 0.88× sales multiple and 4.4% FCF yield keep a floor under the name even if earnings mean-revert toward $5–6B. My base case therefore sits between the two model extremes: MPC is a mature, leveraged, cash-returning refiner whose through-cycle earnings power is closer to $6–8B than to either the $3.3B forward the market is using or the teens-of-billions the optimists still want. At $383 that implies a mid-teens multiple on normalized earnings—neither a bargain nor a short.
The strongest contrary case is straightforward and quantitative. Annualize even half of the June quarter and 2026 net income lands north of $10B; couple that with continued share shrinkage and the trailing multiple compresses into single digits while free-cash-flow yield climbs above 7%. ROIC of 13% and ROE of 17% are already respectable for a heavy-asset business, and the current ratio above 1.25 shows no near-term liquidity stress. A smart opponent would also note that the narrative layer is only “fragile,” not broken—geopolitical crude disruptions and delayed EV penetration have repeatedly extended refining margins longer than consensus models assumed. I weigh that evidence as real but incomplete: one spectacular quarter does not rewrite a five-year downtrend in revenue and FCF, the balance sheet still carries $29B of net debt, and EV/EBITDA of 12× already capitalizes a fair amount of that optimism. Until two more quarters confirm that 9–10% net margins are durable rather than a one-off inventory/crack spike, the $600+ fair-value targets remain model artifacts.
I would flip to a clear undervalued stance if the next two reported quarters each deliver net income above $2.0B and trailing twelve-month FCF holds above $6B, or if management accelerates buybacks enough to cut the share count another 8–10% while net debt stays flat. I would flip to overvalued if crack spreads normalize and quarterly net income falls back below $800M for two consecutive periods, or if the company leverages further to defend the dividend and buyback simultaneously.
Qwen Reading local experiment · off-panel
The single most important number in this briefing is the Q2 2026 net income of $5.14B on $51.99B of revenue, a 9.9% net margin, sitting directly on top of a Q1 2026 that produced $511M on $34.20B of revenue at a 1.5% margin. That is not a trend; that is a one-quarter event. A refiner's revenue jumping 52% quarter-over-quarter is not a volume story — Marathon doesn't suddenly crack 52% more barrels. It is a price story, almost certainly a crude inventory gain from a sharp swing in input costs, possibly compounded by a tax item or settlement. The "accelerating quarterly trend" flagged in the secondary signals is an artifact of this single spike, not a trajectory. Strip out Q2 and the last four quarters of net income are $511M, $1.54B, $1.37B, $1.22B — a company earning roughly $4B a year, not the $10B+ the trailing P/E of 24.23 implies is the new normal. The 24x multiple is a mirage built on 2025's $4.05B, which was itself near the bottom of a five-year earnings collapse from $14.52B in 2022 to $3.45B in 2024. The 35.3% earnings CAGR and 5.4% revenue CAGR are the honest numbers, and they describe a business in secular contraction, not a compounding machine.
What I respect in this data set is the balance sheet and the capital efficiency. Net cash of roughly $1.3B ($3.67B cash against $2.37B debt), a debt-to-equity ratio of 0.098, and a ROIC of 30.5% are genuinely strong for a $90B company. Operating cash flow of $8.25B against capex of $3.49B yields $4.77B in free cash flow, and the FCF quality signal is warranted — this is real cash, not accounting fiction. The P/S of 0.74 and EV/EBITDA of 7.9 are unremarkable for a refiner, but the 4.07x book multiple is where the valuation gets interesting. You are paying four dollars for every dollar of equity in a business whose earnings power has been halving every two years. The 1.22% dividend yield tells you this is not an income play either; the 28% payout ratio means management is conserving cash, which is prudent but also signals they don't expect a sustained earnings recovery.
The prior models are talking past each other, and that's the tell. The Valuation Synthesis lands at $356.25 signal-adjusted, 11% above the current $320.32, and calls the stock undervalued. The Market Forces layer calls it a "value trap" and a "melting ice cube." The Thesis score is -5, barely bearish. The Narrative layer says "steady-compounder" with "minimal" intensity. You cannot simultaneously be a melting ice cube and a steady compounder. I think the truth is closer to the Market Forces read: this is a cyclical commodity processor whose structural revenue base is shrinking (the 5.4% revenue CAGR is not a cycle, it's the energy transition eating gasoline demand), and the Q2 2026 spike is the kind of one-quarter windfall that makes a trailing P/E look deceptively cheap. The "scarcity value" thesis in the Pre-Flight layer — that declining global refining capacity supports margins — is plausible but it's a bet on geopolitics and OPEC discipline, not on Marathon's own operational trajectory.
The strongest case against my skepticism is the ROIC. Thirty percent return on invested capital is extraordinary for a refiner, and it means that even in a "bad" year, the capital base is generating meaningful returns. The net-cash position means there is no debt overhang, no refinancing risk, no interest expense eating into the already-thin margins. And the MPLX midstream subsidiary, while not broken out in this data, provides a fee-based revenue stream that is less exposed to crack spread volatility than the refining segment. A smart bull would argue that the market is anchoring on the 2022-to-2024 earnings decline and ignoring that the capital structure has been de-risked, that the $3.49B capex is being deployed into renewable diesel (a growth option, not just maintenance), and that at 0.7x sales with 30% ROIC, the risk/reward is asymmetric to the upside if crack spreads normalize. I weigh this differently because the ROIC is a trailing number that was 30%+ in 2022 when earnings were $14.5B; in 2024, with earnings at $3.45B, the effective ROIC was materially lower. The 30% figure is a peak-cycle artifact, not a steady-state.
What would change my mind in either direction: a Q3 2026 print that sustains net margins above 5% on revenue in the $33-35B range (i.e., the Q2 spike was not a one-time inventory event but a genuine crack spread recovery) would push me toward undervalued, because it would validate the "trough earnings" thesis and make the 24x trailing P/E a floor rather than a ceiling. Conversely, if Q3 margins revert to the 2-4% range and the company guides 2026 full-year earnings back toward $4-5B, the 24x multiple becomes 18-22x on a declining earnings base, and the 4x book multiple looks rich for a business with a 5.4% revenue CAGR. I would also watch the MPLX segment disclosure in the next 10-Q: if midstream fees are holding steady while refining margins compress, the "fortress" narrative gains credibility; if both segments are soft, the structural decline is confirmed.
Big-3 Panel — where each AI stands
Claude — Second Response · overvalued revised
VERDICT: Overvalued but tightening — fair value $260-285 (raised for explicit MPLX credit) vs $320; the entire bull case rests on Q3/Q4 2026 confirming June wasn't a one-quarter windfall, and I'll flip to fair if two consecutive $2.5B+ NI quarters print.
Neither colleague moved me off the direction, but GPT's framing sharpened one thing worth naming: the TTM-through-June-2026 earnings power is ~$8.5B, and if that's mid-cycle rather than peak, the stock is not obviously expensive at 10-11x. That's the real hinge, and I gave it short shrift in my first pass by treating Q2 2026 as pure anomaly. Grok leans on the same math but calls it a re-rating of a trough — I don't buy that framing because 2025 full-year net margin was 3.0% and Q1 2026 was 1.5%, which are not trough prints in any historical sense for MPC; they're normal-to-weak refining quarters. You cannot call June 2026 "the cycle turning" when the quarter immediately before it earned $511M. One quarter is a data point, not a trend, and Grok's compression of 24x into "10-11x on fresher earnings" is exactly the trailing-composite trick I flagged.
Where GPT's discipline actually helps: his condition — "prove it with two more quarters above $2.5-3.0B NI" — is the right test, and I should adopt it rather than dismiss the possibility outright. If Q3 and Q4 2026 both print $2.5B+, my $240-270 fair value is wrong and $320 is defensible. That's a real fork, and I'll acknowledge the asymmetry: I'm short a call on capacity rationalization (Lyondell, PBF, global closures) that could genuinely re-rate mid-cycle margins higher for 2-3 years. Grok is right that midstream (MPLX distributions to parent) deserves explicit SOTP credit I didn't quantify — probably $40-50/share of the equity value is a reasonable midstream annuity, which tightens my fair value band upward toward $260-280 rather than $240-270.
Net: I'm holding overvalued but narrowing the gap. The Q2 print is one quarter, the 5-year earnings CAGR is -35%, and paying $90B cap for a business whose 2025 full-year net margin was 3% requires believing in a mid-cycle regime that has not yet been demonstrated across consecutive quarters. Grok is buying that regime on one print; I'm not.
GPT — Second Response · overvalued revised
VERDICT: Modestly overvalued at $320; fair value remains about $250–280, with upside only if post-Q2 2026 earnings hold above roughly $2.5–3.0B per quarter.
Claude’s critique largely reinforced my original caution, but the specific point that moved me was not “Q2 2026 was huge” — I already said that — it was the juxtaposition with Q1 2026: $34.2B revenue and just $511M net income, then one quarter later $51.99B and $5.14B. That swing is too violent to treat the trailing-four-quarter $8.5B earnings figure as a clean normalized base. For a refiner, the burden of proof has to sit with the bull when one quarter contributes more profit than the entire prior year. I also think Claude’s sum-of-parts reminder on MPLX is fair and keeps me from getting aggressively bearish; this is not a distressed pure-play refiner and the net-cash parent balance sheet plus midstream cash annuity justify a premium to a commodity crack-spread screen.
What did not move me was Grok’s claim that the “down-cycle just ended” and that 10–11x on fresher earnings is the right anchor. That only works if you accept the June 2026 quarter as evidence of a new run-rate rather than a dislocation, and I still don’t. Q1 2026’s 1.5% net margin is the cleaner reminder of how quickly refining economics can evaporate. Yes, 7.9x EV/EBITDA and 0.74x sales are not obviously expensive in isolation, and yes, MPC’s quality is above average for the group. But revenue, earnings, and FCF multi-year trajectories remain negative, the dividend yield is modest, and the stock has already rerated massively ahead of a fully demonstrated annual recovery. So I’m revising only in degree: I’m more comfortable saying “overvalued on normalized earnings” rather than merely “fair at best,” but only modestly so because the balance sheet and MPLX support a floor above generic-refiner math.
Grok — Second Response · overvalued changed direction
VERDICT: Fairly valued to mildly overvalued at $320; normalized $4–5B earnings and midstream credit support ~$270–300, not $350+
The single-quarter spike argument is the point that forces a revision. Both colleagues correctly flag that June 2026’s $5.14B net income on a 9.9% margin—ten times the prior quarter and more than the entire prior year—is a crack-spread/inventory windfall, not a new run-rate. My first read compressed the multiple by leaning too hard on a TTM that now embeds that print; strip it and the earnings envelope reverts toward the $3.5–5B range that defined 2024–25. At a $90B equity value, that is 18–26x normalized earnings for a pure-play cyclical whose revenue and FCF CAGRs remain deeply negative. Claude’s $240–270 and GPT’s $260–280 bands are directionally right once the mirage is removed; I was underweighting how little margin of safety remains if cracks mean-revert inside two quarters.
What still fails to move me all the way to a deep-value-trap call is the balance-sheet and midstream reality both colleagues concede. Net cash, 30% ROIC, sub-0.1 debt/equity, and the MPLX cash annuity are not illusory; they justify a premium to a generic refiner and keep floor value closer to $270–300 than Claude’s lower bound. Capacity rationalization and sticky gasoline demand also keep the secular-destruction case from being decisive on a 3-year horizon. Still, the stock has already doubled off the $158 low on what remains one anomalous quarter and flat multi-year fundamentals. That is late-cycle re-rating, not mispriced trough earnings power.
I therefore revise from “modestly undervalued / $350–380” to roughly fairly valued with a mild overvaluation bias at $320. I would need the next two quarters to print combined net income above ~$5B and FCF annualizing near $7B+ before reclaiming an undervalued stance.
Advanced Analysis Forensic deep-dive · separate lenses
MPC is a mature downstream energy earner running through a classic refining cycle. Revenue peaked at $177.5B in 2022 with 12.1% operating margins and $13.9B FCF, then compressed to $132.7B revenue, 6.2% op margin, and $4.77B FCF by 2025. Net income has fallen from $14.5B (2022) to $4.05B (2025) — a roughly 72% drop from peak, showing the commodity-tied nature of the business. Earnings quality is clean: OCF/NI of 1.52x, accruals -2.5% of assets, Beneish M -2.82, and Altman Z 3.72 all support that reported profits are backed by cash. The balance sheet carries net debt of $29.2B against $3.67B liquid cash; not distressed given $4.77B annual FCF, but it is a constraint rather than a cushion. Capital returns are heavy: buybacks are 54x SBC, and share count has actually declined from 341M (2024) to 306M (2025), though the 5-year diluted CAGR of ~2% reflects a 2024 bulge worth investigating. Insider activity is mildly negative — four sales totaling $7.3M, zero open-market buys — but at modest scale for an executive team, consistent with routine option-exercise-and-sell behavior rather than a red flag.
Verify before trusting this (5)
- What drove the 2024 diluted share count spike to 341M — convertible dilution, acquisition-related issuance, or accounting artifact?
- Debt maturity ladder and refinancing exposure across the $29B+ gross debt stack
- Segment mix between Refining, Midstream (MPLX), and Retail — MPLX contribution to consolidated FCF matters for durability read
- Whether the 2025 op margin recovery to 6.2% reflects structural cost actions or just crack spread mean reversion
- Details on the option-exercise-and-sell pattern — pre-set 10b5-1 plans versus discretionary sales
The e2e composite FV of $701.75 and signal-adjusted $623.80 imply 63% upside, but the spread across methods is enormous - EPV floor $238.72, DCF $777.79, anchored P/E $1,012.70 - which screams that the high-end methods are extrapolating peak-cycle or normalized earnings that a leveraged cyclical refiner does not durably earn. The anchored-PE at $1,012 is essentially unusable; it's more than 2.6x the current price on a business whose net income fell 76% peak-to-trough. Weight the EPV floor heavily and the DCF partially and you land in a deserved-value band of roughly $400-500 per share for a Solid-quality refiner with $29B net debt. Against $383, that's a modest 5-25% discount - real, but not a fat pitch. Earnings quality is clean (no haircut), and the MPLX midstream stream gives the cash-return story genuine support. What's priced in: the market accepts mid-cycle cash generation continues and buybacks keep shrinking the share count, but discounts terminal demand risk from EV penetration. To call this Deep Value you'd need to believe refining margins normalize higher for a decade; the bear case on structural fuel demand decline is credible enough to keep this a modest, not a screaming, discount.
Verify before trusting this (5)
- Mid-cycle refining crack spread assumptions embedded in the DCF vs 10-year historical average
- MPLX distribution durability and any structural changes to the midstream cash stream
- Guidance on buyback pace and remaining authorization
- Management commentary on demand outlook and refinery rationalization plans
- Any one-time working capital or inventory gains inflating recent earnings
The sentiment picture for MPC has flipped constructive in the very short term. Goldman is publicly flagging a global fuel squeeze and another refining windfall, U.S. strikes near the Strait of Hormuz are sending oil equities to record highs, and peer Valero is printing 52-week highs - refiners are the trade of the moment. That is a direct, name-specific tailwind for MPC as a scaled, pure-play refiner with MPLX cash flow, and recent big-move causes confirm the tape is already rewarding it (Q2 beat plus crude rally already delivered a 5% up-day in August). Low beta (0.51) means the mildly soft broader tape (S&P -2.2%, VIX 16) barely touches this name; sector-specific flow dominates. On the other side, the structural narrative is still fragile and late-cycle: bear story is 'sunset industry', 3-year momentum is negative, D/E has crept up, and there is a persistent DCF-to-price gap the market refuses to close because it doubts terminal refining economics. Analyst tone within the group is bullish on refiners broadly, but MPC is not the anointed leader (VLO is getting the headline). Net: a real, active cyclical tailwind riding on top of a fragile long-duration bear narrative - the near-term press is up.
Verify before trusting this (4)
- Whether crack spreads actually widen in the next 2-4 weeks or the 'fuel squeeze' call fades
- Sell-side target revisions on MPC specifically (not just VLO) following the Goldman refining call
- Any de-escalation headlines on Hormuz that would deflate the geopolitical bid
- Whether MPC starts leading the group or continues to lag VLO on up-days
The world is doing two contradictory things to refiners at once, and both are real. Demand for transport fuels is structurally flattening then declining in developed markets as electrification scales — that is the category's -8% revenue CAGR and the bear case. But the supply side is closing faster than demand is falling: no new Western capacity, permanent shutdowns on the US West Coast and in Europe, and capital markets that will not fund a 30-year refinery. That asymmetry is why mid-cycle margins can stay structurally higher even as volumes shrink, and it is the specific reason a sunset industry can still produce expanding earnings power for the lowest-cost survivors. MPC is positioned as one of those survivors: scale, complexity, integrated midstream cash flow, and a capital policy that shrinks the equity base rather than the asset base. The macro layer (4.75% 10y, flagged headwinds) cuts the other way on industrial/freight-driven distillate demand and is the most likely source of a near-term disappointment.
When we made this prediction on Sep 2, 2026, MPC was $388.08. We expect it to be $495.00 by Mar 2027, and we consider it great value under $320.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 2, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence UNSETTLED
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.
trailing_eps
flips down 5%
adjusted_pe
flips down 5%
cost_of_capital
flips down 25%